(Q36974042)

17 August 2017

1 reference

title

Autoantibodies as mechanisms, markers, and mediators of B-cell disease (English)

1 reference

17 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

27 November 2022

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

27 November 2022

author name string

T. J. Wilkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1794256

27 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1794256

27 November 2022

publication date

1 June 1991

1 reference

full work available at URL

17 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdmr.5610070204

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmr.5610070204/fullpdf

27 November 2022

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Diabetes/metabolism reviews

27 November 2022

published in

1 reference

17 August 2017

7

1 reference

17 August 2017

2

1 reference

17 August 2017

105-120

1 reference

Pathologic anatomy of the pancreas in juvenile diabetes mellitus

17 August 2017

4

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The pancreatic islets in diabetes

27 November 2022

6

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

27 November 2022

7

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus

27 November 2022

8

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islets of Langerhans in juvenile diabetes mellitus

27 November 2022

10

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Examination of islets in the pancreas biopsy specimens from newly diagnosed Type 1 (insulin-dependent) diabetic patients

27 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Generalized Islet Hypertrophy and Beta-Cell Hyperplasia in a Case of Long-Term Juvenile Diabetes

27 November 2022

13

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus

27 November 2022

14

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Systematic variation and differences in insulin-autoantibody measurements

27 November 2022

15

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Inhibition of Insulin Release after Passive Transfer of Immunoglobulin from Insulin-Dependent Diabetic Children to Mice*

27 November 2022

16

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The natural history of insulin secretion in type 1 diabetes

27 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study

27 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Escaping insulin dependent diabetes

27 November 2022

19

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Expression of reg protein in rat regenerating islets and its co-localization with insulin in the beta cell secretory granules

27 November 2022

20

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies

27 November 2022

21

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The Relationship Between Insulin Autoantibodies and Islet Cell Histology in the Diabetes Prone BB Rat

27 November 2022

23

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Passive transfer of diabetes in the BB/W rat

27 November 2022

24

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

H gene theory of inherited autoimmune disease

27 November 2022

25

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The immunoregulatory disturbance in autoimmune thyroid disease

27 November 2022

26

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Failure to find holes in the T-cell repertoire

27 November 2022

27

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Is there restricted T cell receptor usage in autoimmune disease?

27 November 2022

28

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Unresponsiveness to self antigens

27 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

An immunological cross-reaction between group-A streptococcal cells and human heart tissue

27 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Diabetes in identical twins. A study of 200 pairs

27 November 2022

32

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Evidence for a food additive as a cause of ketosis-prone diabetes

27 November 2022

33

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Virus Persists in β Cells of Islets of Langerhans and Is Associated with Chemical Manifestations of Diabetes

27 November 2022

35

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

27 November 2022

Viruses and autoimmunity

36

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells

27 November 2022

37

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes

27 November 2022

38

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma

27 November 2022

39

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The complex role of epithelial cell MHC class II antigen expression in autoimmune endocrine disease

27 November 2022

40

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Immune interferon: a pleiotropic lymphokine with multiple effects

27 November 2022

41

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Autoantibodies and the physiological role of immunoglobulins

27 November 2022

42

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Autoimmunity: attack, or defence? (The case for a primary lesion theory).

27 November 2022

43

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Thyroid-stimulating immunoglobulins in Graves' disease

27 November 2022

45

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The behaviour of thyroid hormones in an infant with untreated neonatal thyrotoxicosis

27 November 2022

46

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Transient Neonatal Hypothyroidism Due to Maternal Immunoglobulins that Inhibit Thyrotropin-Binding and Post-Receptor Processes

27 November 2022

47

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease

27 November 2022

48

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Antibodies that block stimulation by TSH or TSAb of thyroid hormone secretion in primary hypothyroidism

27 November 2022

49

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Immune mechanisms in Graves' disease

27 November 2022

50

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies

27 November 2022

51

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet Cell Surface Antibodies from Insulin-dependent Diabetics Bind Specifically to Pancreatic B Cells

27 November 2022

52

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins

27 November 2022

53

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet-cell antibodies in diabetes mellitus

27 November 2022

55

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage

27 November 2022

56

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Immunology and Diabetes Workshop: report on the Third International (Stage 3) Workshop on the Standardisation of Cytoplasmic Islet Cell Antibodies. Held in New York, New York, October 1987

27 November 2022

57

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Predicting insulin-dependent diabetes

27 November 2022

58

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

27 November 2022

59

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Predicting insulin-dependent diabetes

27 November 2022

61

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins

27 November 2022

62

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes

27 November 2022

63

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes

27 November 2022

64

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet cell antibodies in patients with autoimmune thyroid disease

27 November 2022

65

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children

27 November 2022

68

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Recognition of common islet antigen by autoantibodies from NOD mice and humans with IDDM.

27 November 2022

70

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays.

27 November 2022

71

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Predicting type I diabetes

27 November 2022

72

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment

27 November 2022

73

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus

27 November 2022

74

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus

27 November 2022

75

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The Third International Workshop on the Standardisation of Insulin Autoantibody Measurement

27 November 2022

77

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987.

27 November 2022

79

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

The Fourth International Workshop on the Standardisation of Insulin Autoantibody Workshop.

27 November 2022

80

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Autoantibodies against human insulin

27 November 2022

82

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus.

27 November 2022

84

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Insulin antibodies in patients receiving penicillamine

27 November 2022

85

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis

27 November 2022

87

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Autoantibodies to insulin do appear in non-diabetic patients with autoimmune disorders: comparison with anti-immunoglobulin antibodies and other autoimmune phenomena

27 November 2022

88

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy

27 November 2022

89

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study

27 November 2022

90

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes

27 November 2022

91

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus

27 November 2022

93

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

A comparison of childhood and adult type I diabetes mellitus

27 November 2022

94

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes

27 November 2022

97

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans

27 November 2022

100

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes

27 November 2022

101

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

64,000 Mr autoantibodies as predictors of insulin-dependent diabetes

27 November 2022

102

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis?

27 November 2022

103

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell

27 November 2022

104

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach

27 November 2022

105

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity

27 November 2022

106

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

27 November 2022

107

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

27 November 2022

109

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

64,000-Mr autoantigen in type I diabetes. Evidence against its surface location on human islets

27 November 2022

110

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Receptor autoimmunity in endocrine disorders

27 November 2022

111

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Immunoglobulin from Insulin-dependent Diabetic Children Inhibits Glucose-induced Insulin Release

27 November 2022

112

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus

27 November 2022

114

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Graves' disease of the beta cell: glucose dysregulation due to islet-cell stimulating antibodies

27 November 2022

115

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Plasma from BB/Wor rats increases insulin secretion by perfused rat pancreas

27 November 2022

116

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Hypoglycemia due to apparent autoantibodies to insulin. Characterization of insulin-binding protein

27 November 2022

118

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Relevance of endocrine pancreas nesidioblastosis to hyperinsulinemic hypoglycemia

27 November 2022

119

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Familial Cushing's syndrome due to nodular adrenocortical dysplasia. A putative receptor-antibody disease?

27 November 2022

120

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Increased preproinsulin mRNA in pancreatic islets incubated with islet cell-stimulating antibodies from serums of type I diabetic patients

27 November 2022

121

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Antibodies That Impair Insulin Receptor Binding in an Unusual Diabetic Syndrome with Severe Insulin Resistance

27 November 2022

122

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Hypoglycemia associated with antibodies to the insulin receptor.

27 November 2022

123

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man

27 November 2022

124

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Human autoantibodies directed against the human, but not the rat, insulin receptor

27 November 2022

125

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Characterization of the Serum from a Patient with Insulin Resistance and Hypoglycemia: Evidence for Multiple Populations of Insulin Receptor Antibodies with Different Receptor Binding and Insulin-mimicking Activities

27 November 2022

126

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Assay of antibodies directed against cell surface receptors

27 November 2022

127

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Binding of insulin to its receptor impairs recognition by monoclonal anti-insulin antibodies.

27 November 2022

128

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Immunoprecipitation of insulin receptors from cultured human lymphocytes (IM-9 cells) by antibodies to pp60src

27 November 2022

129

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Clinical disorders associated with autoantibodies to the insulin receptor. Simulation by passive transfer of immunoglobulins to rats

27 November 2022

131

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Impaired in vivo insulin clearance in patients with severe target-cell resistance to insulin

27 November 2022

132

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Antibody against the insulin receptor causes disappearance of insulin receptors in 3T3-L1 cells: a possible explanation of antibody-induced insulin resistance

27 November 2022

133

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody

27 November 2022

134

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Islet-Cell-Surface Antibodies in Juvenile Diabetes Mellitus

27 November 2022

135

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Circulating anti-immunoglobulin antibodies in recent-onset type I diabetic patients

27 November 2022

137

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment

27 November 2022

139

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070204

27 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1794256

27 November 2022

1 reference